Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group

OBJECTIVE: Patients with platinum-resistant ovarian cancer (PROC) have a high need for reliable prognostic markers. Since significance of primary platinum resistance (PPR) versus secondary platinum resistance (SPR) was identified for patients receiving anti-angiogenic therapy, it has not been confir...

Descripción completa

Detalles Bibliográficos
Autores principales: Trillsch, Fabian, Mahner, Sven, Czogalla, Bastian, Rottmann, Miriam, Chekerov, Radoslav, Braicu, Elena Ioana, Oskay-Öczelik, Gülten, Wimberger, Pauline, Richter, Rolf, Sehouli, Jalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039167/
https://www.ncbi.nlm.nih.gov/pubmed/33825355
http://dx.doi.org/10.3802/jgo.2021.32.e37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039167/
https://www.ncbi.nlm.nih.gov/pubmed/33825355
http://dx.doi.org/10.3802/jgo.2021.32.e37

Ejemplares similares